中国抗癌协会胰腺癌专业委员会. 中国抗癌协会胰腺癌整合诊治指南(精简版)[J]. 中国肿瘤临床, 2023, 50(10): 487-496. DOI: 10.12354/j.issn.1000-8179.2023.20221544
引用本文: 中国抗癌协会胰腺癌专业委员会. 中国抗癌协会胰腺癌整合诊治指南(精简版)[J]. 中国肿瘤临床, 2023, 50(10): 487-496. DOI: 10.12354/j.issn.1000-8179.2023.20221544
China Anti-Cancer Association Committee of Pancreatic Cancer. China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer (abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(10): 487-496. DOI: 10.12354/j.issn.1000-8179.2023.20221544
Citation: China Anti-Cancer Association Committee of Pancreatic Cancer. China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer (abridged version)[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(10): 487-496. DOI: 10.12354/j.issn.1000-8179.2023.20221544

中国抗癌协会胰腺癌整合诊治指南(精简版)

China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer (abridged version)

  • 摘要: 胰腺癌在中国男性恶性肿瘤发病率居第10位,女性居第12位,恶性肿瘤死亡率居第6位。胰腺癌恶性程度高,预后极差。在“整合医学”理念的推动下,中国抗癌协会胰腺癌专业委员会组织相关专家制订指南,旨在以“防-筛-诊-治-康”为基础,全面、全程地指导胰腺癌的整合治疗和康复管理。期望本指南可以为临床医师提供参考意见,从而提高国内胰腺癌患者的治疗效果。

     

    Abstract: Pancreatic cancer ranks 10th in the incidence rate of malignant tumors in men and 12th in women, and is the 6th leading cause of tumor-related deaths in China. It is a devastating malignancy with a poor prognosis. Inspired by the concept of “integrated medicine,” the China Anti-Cancer Association Committee of Pancreatic Cancer has organized the efforts of relevant experts to complete these guidelines for the integrative and comprehensive treatment and rehabilitation management of pancreatic cancer based on the principles of “Preventing, Screening, Diagnosing, Treating, and Rehabilitating.” We hope that these guidelines will constitute an effective reference for clinicians in achieving the best treatment outcomes for patients with pancreatic cancer in China.

     

/

返回文章
返回